The study was initiated and sponsored by TEVA Pharmaceuticals, which markets deutetrabenazine (Austedo), one of two approved treatments for tardive dyskinesia.
1 Like
The study was initiated and sponsored by TEVA Pharmaceuticals, which markets deutetrabenazine (Austedo), one of two approved treatments for tardive dyskinesia.